Table 3.

Medication of patients with CAH

Men with CAHWomen with CAH
Glucocorticoids
 Hydrocortisone14.5 (48.3)12 (41.4)
 Prednisolone11.5 (38.3)15 (51.7)
 Dexamethasone4 (13.3)2 (6.9)
 Equivalent dosage, mg30 (23.8-32.5)22.5 (20.0-30.0)
 Equivalent dosage, mg/m214.74 (12.3-17.9)13.2 (11.9-15.6)
 Circadian administration regimen30 (100)29 (100)
Fludrocortisone21 (70.0)20 (69.0)
Dosage, mg0.1 (0.0875-0.125)0.075 (0.05-0.1)
Men with CAHWomen with CAH
Glucocorticoids
 Hydrocortisone14.5 (48.3)12 (41.4)
 Prednisolone11.5 (38.3)15 (51.7)
 Dexamethasone4 (13.3)2 (6.9)
 Equivalent dosage, mg30 (23.8-32.5)22.5 (20.0-30.0)
 Equivalent dosage, mg/m214.74 (12.3-17.9)13.2 (11.9-15.6)
 Circadian administration regimen30 (100)29 (100)
Fludrocortisone21 (70.0)20 (69.0)
Dosage, mg0.1 (0.0875-0.125)0.075 (0.05-0.1)

Presentation of values as median (interquartile range) or n (%).

Abbreviations: CAH, congenital adrenal hyperplasia.

Table 3.

Medication of patients with CAH

Men with CAHWomen with CAH
Glucocorticoids
 Hydrocortisone14.5 (48.3)12 (41.4)
 Prednisolone11.5 (38.3)15 (51.7)
 Dexamethasone4 (13.3)2 (6.9)
 Equivalent dosage, mg30 (23.8-32.5)22.5 (20.0-30.0)
 Equivalent dosage, mg/m214.74 (12.3-17.9)13.2 (11.9-15.6)
 Circadian administration regimen30 (100)29 (100)
Fludrocortisone21 (70.0)20 (69.0)
Dosage, mg0.1 (0.0875-0.125)0.075 (0.05-0.1)
Men with CAHWomen with CAH
Glucocorticoids
 Hydrocortisone14.5 (48.3)12 (41.4)
 Prednisolone11.5 (38.3)15 (51.7)
 Dexamethasone4 (13.3)2 (6.9)
 Equivalent dosage, mg30 (23.8-32.5)22.5 (20.0-30.0)
 Equivalent dosage, mg/m214.74 (12.3-17.9)13.2 (11.9-15.6)
 Circadian administration regimen30 (100)29 (100)
Fludrocortisone21 (70.0)20 (69.0)
Dosage, mg0.1 (0.0875-0.125)0.075 (0.05-0.1)

Presentation of values as median (interquartile range) or n (%).

Abbreviations: CAH, congenital adrenal hyperplasia.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close